SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001005286-25-000012
Filing Date
2025-01-02
Accepted
2025-01-02 17:15:33
Documents
89
Period of Report
2024-11-24

Document Format Files

Seq Description Document Type Size
1 10-Q lfcr-20241124.htm   iXBRL 10-Q 1129923
2 EX-31.1 lfcr-20241124xexx311.htm EX-31.1 11575
3 EX-31.2 lfcr-20241124xexx312.htm EX-31.2 11195
4 EX-32.1 lfcr-20241124xexx321.htm EX-32.1 5729
5 EX-32.2 lfcr-20241124xexx322.htm EX-32.2 5606
  Complete submission text file 0001005286-25-000012.txt   7204757

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfcr-20241124.xsd EX-101.SCH 42773
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfcr-20241124_cal.xml EX-101.CAL 73943
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfcr-20241124_def.xml EX-101.DEF 313264
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfcr-20241124_lab.xml EX-101.LAB 685678
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfcr-20241124_pre.xml EX-101.PRE 502863
92 EXTRACTED XBRL INSTANCE DOCUMENT lfcr-20241124_htm.xml XML 908615
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
Type: 10-Q | Act: 34 | File No.: 000-27446 | Film No.: 25502989
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)